908 Devices Inc

Company Profile

908 Devices Inc had its IPO on 2020-12-18 under the ticker symbol MASS.

The company operates in the Healthcare sector and Medical Devices industry. 908 Devices Inc has a staff strength of 227 employees.

Stock update

Shares of 908 Devices Inc opened at $6.45 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $6.22 - $6.47, and closed at $6.34.

This is a -2.01% slip from the previous day's closing price.

A total volume of 106,054 shares were traded at the close of the day’s session.

In the last one week, shares of 908 Devices Inc have slipped by -10.83%.

908 Devices Inc's Key Ratios

908 Devices Inc has a market cap of $226.99 million, indicating a price to book ratio of 1.4363 and a price to sales ratio of 5.3919.

In the last 12-months 908 Devices Inc’s revenue was $49.02 million with a gross profit of $26.02 million and an EBITDA of $-38942000. The EBITDA ratio measures 908 Devices Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, 908 Devices Inc’s operating margin was -84.08% while its return on assets stood at -11.25% with a return of equity of -20.2%.

In Q2, 908 Devices Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 8.9%.

908 Devices Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-1.12 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into 908 Devices Inc’s profitability.

908 Devices Inc stock is trading at a EV to sales ratio of 2.1233 and a EV to EBITDA ratio of -4.2008. Its price to sales ratio in the trailing 12-months stood at 5.3919.

908 Devices Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$210.83 million

Total Liabilities

$20.19 million

Operating Cash Flow

$-19936000.00

Capital Expenditure

$320000

Dividend Payout Ratio

0%

908 Devices Inc ended 2024 with $210.83 million in total assets and $0 in total liabilities. Its intangible assets were valued at $210.83 million while shareholder equity stood at $174.46 million.

908 Devices Inc ended 2024 with $2.59 million in deferred long-term liabilities, $20.19 million in other current liabilities, 32000.00 in common stock, $-156078000.00 in retained earnings and $10.19 million in goodwill. Its cash balance stood at $133.00 million and cash and short-term investments were $152.69 million. The company’s total short-term debt was $1,860,000 while long-term debt stood at $0.

908 Devices Inc’s total current assets stands at $181.08 million while long-term investments were $0 and short-term investments were $19.69 million. Its net receivables were $10.31 million compared to accounts payable of $1.49 million and inventory worth $14.14 million.

In 2024, 908 Devices Inc's operating cash flow was $-19936000.00 while its capital expenditure stood at $320000.

Comparatively, 908 Devices Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$6.34

52-Week High

$18.02

52-Week Low

$5.69

Analyst Target Price

$17

908 Devices Inc stock is currently trading at $6.34 per share. It touched a 52-week high of $18.02 and a 52-week low of $18.02. Analysts tracking the stock have a 12-month average target price of $17.

Its 50-day moving average was $7.1 and 200-day moving average was $8.18 The short ratio stood at 6.51 indicating a short percent outstanding of 0%.

Around 800.4% of the company’s stock are held by insiders while 8653.2% are held by institutions.